2cureX’s CEO Fernando Andreu is buying shares in the company
2cureX AB announces that CEO Fernando Andreu has bought 7.987 shares for approx. 0,15 MSEK.For more information, please contact:Fernando AndreuChief Executive OfficerTel: +45 22 79 53 99E-mail: fa@2curex.com Certified Adviser Redeye AB Phone: +46 8 121 576 90 Mail: certifiedadviser@redeye.se About 2cureX 2cureX has developed the IndiTreat® (Individual Treatment) test. IndiTreat® establishes thousands of 3D microtumors that functionally resemble the patient's tumor and identifies the approved cancer treatment that most effectively kills the patient's tumor.